Adverse Drug Event: Clinical Trials

8 trials for Adverse Drug Event, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 recruiting, 1 unknown. 8 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 48Completed 6, Recruiting 1, Unknown 1

Follow Adverse Drug Event: new trials by email Literature Review of Adverse Drug Event trials Research Report on Adverse Drug Event

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Remimazolam Besylate for Sedation in Post-Non-Cardiac Surgery Patients Requiring Mechanical Ventilation
Remimazolam Besylate, Dexmedetomidine Hydrochloride - Effect of Drug, Adverse Drug Event
Phase 4RecruitingBeijing Shijitan Hospital, Capital Medical University3062025-01-202026-06-16
Oliceridine in Patients With Acute Burn Injuries
Oliceridine, Historical opioid use - Acute Pain, Burns
Phase 4CompletedUniversity of Tennessee312023-04-012023-10-26
Simultaneous mRNA COVID-19 and IIV4 Vaccination Study
mRNA COVID-19, IIV4, Placebo (saline) - Quality of Life, Injection Site Reaction
Phase 4CompletedDuke University3482021-10-042024-03-19
Simultaneous RZV and aIIV4 Vaccination
FLUAD® Quadrivalent, Fluzone® High-Dose Quadrivalent, SHINGRIX® - Pain, Quality of Life
Phase 4CompletedDuke University2672021-09-212024-07-11
Research on Human Insulin rDNA Safety and Efficacy in Patients With Type 2 Diabetes Mellitus
Insulin - Adverse Drug Event, Effect of Drug
Phase 4CompletedGetz Pharma2382021-01-012023-02-06
Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification
Atropine sulfate and epinephrine, Topical cyclopentolate and phenylephrine - Cataract, Mydriasis
Phase 4UnknownDar El Oyoun Hospital402018-09-282018-10-09
FLUAD® vs. Fluzone® High-Dose Study
FLUAD®, Fluzone® High-Dose - Pain, Quality of Life
Phase 4CompletedDuke University7572017-08-282021-03-30
PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment
ERIBULIN MESYLATE - Metastatic Breast Cancer, Toxicity
Phase 4CompletedOncologia Medica dell'Ospedale Fatebenefratelli2002014-05-012021-03-04

Narrower conditions

Drug-Related Side Effects and Adverse Reactions (8)  ·  Influenza, Human (3)  ·  Injection Site Reaction (3)  ·  Pain (2)  ·  Acute Pain (1)  ·  Breast Neoplasms (1)  ·  Burns (1)  ·  COVID-19 (1)  ·  Cataract (1)  ·  Critical Illness (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Insulin Resistance (1)  ·  Mydriasis (1)  ·  Neurotoxicity Syndromes (1)  ·  Postoperative Nausea and Vomiting (1)

Broader conditions

Chemically-Induced Disorders (8)  ·  Pathologic Processes (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Respiratory Tract Diseases (4)  ·  Extravasation of Diagnostic and Therapeutic Materials (3)  ·  Infections (3)  ·  Neurologic Manifestations (3)  ·  Orthomyxoviridae Infections (3)  ·  RNA Virus Infections (3)  ·  Respiratory Tract Infections (3)  ·  Signs and Symptoms (3)  ·  Virus Diseases (3)  ·  Breast Diseases (1)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)

Interventions

Influenza Vaccines (2)  ·  ((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine (1)  ·  2019-nCoV Vaccine mRNA-1273 (1)  ·  Atropine (1)  ·  Cyclopentolate (1)  ·  Dexmedetomidine (1)  ·  Epinephrine (1)  ·  Insulin (1)  ·  Phenylephrine (1)  ·  Sodium Chloride (1)  ·  eribulin (1)  ·  fluad vaccine (1)

Sponsors

Duke University (3)  ·  Beijing Shijitan Hospital, Capital Medical University (1)  ·  Dar El Oyoun Hospital (1)  ·  Getz Pharma (1)  ·  Oncologia Medica dell'Ospedale Fatebenefratelli (1)  ·  University of Tennessee (1)

Countries

United States (4)  ·  China (1)  ·  Egypt (1)  ·  Italy (1)  ·  Pakistan (1)

Top investigators

Kenneth Schmader, MD (2)  ·  Elizabeth Barnett, MD (1)  ·  Elizabeth Schlaudecker, MD, MPH (1)  ·  Emmanuel B Walter, MD, MPH (1)  ·  Giovanna Damia, PHD (1)  ·  Jianxin Zhou, doctor (1)  ·  Karen R Broder, MD (1)  ·  Kawsar Talaat, MD (1)  ·  Theresa Harrington, MD (1)

Results publications

PMID 33443580, PMID 36307826, PMID 37393237, PMID 37781954, PMID 39446325, PMID 39504023, PMID 41380398